HES3: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: HTTP→HTTPS)
 
imported>Rjwilmsi
(→‎Further reading: 10.3892/ijo.31.2.461)
 
Line 8: Line 8:
{{refbegin | 2}}
{{refbegin | 2}}
* {{cite journal | vauthors = Katoh M, Katoh M | title = Identification and characterization of human HES2, HES3, and HES5 genes in silico | journal = International Journal of Oncology | volume = 25 | issue = 2 | pages = 529–34 | date = August 2004 | pmid = 15254753 | doi = 10.3892/ijo.25.2.529 }}
* {{cite journal | vauthors = Katoh M, Katoh M | title = Identification and characterization of human HES2, HES3, and HES5 genes in silico | journal = International Journal of Oncology | volume = 25 | issue = 2 | pages = 529–34 | date = August 2004 | pmid = 15254753 | doi = 10.3892/ijo.25.2.529 }}
* {{cite journal | vauthors = Katoh M, Katoh M | title = Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer | journal = International Journal of Oncology | volume = 31 | issue = 2 | pages = 461–6 | date = August 2007 | pmid = 17611704 }}
* {{cite journal | vauthors = Katoh M, Katoh M | title = Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer | journal = International Journal of Oncology | volume = 31 | issue = 2 | pages = 461–6 | date = August 2007 | pmid = 17611704 | doi = 10.3892/ijo.31.2.461 }}
* {{cite journal | vauthors = Fukami M, Wada Y, Okada M, Kato F, Katsumata N, Baba T, Morohashi K, Laporte J, Kitagawa M, Ogata T | title = Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence | journal = The Journal of Biological Chemistry | volume = 283 | issue = 9 | pages = 5525–32 | date = February 2008 | pmid = 18162467 | doi = 10.1074/jbc.M703289200 }}
* {{cite journal | vauthors = Fukami M, Wada Y, Okada M, Kato F, Katsumata N, Baba T, Morohashi K, Laporte J, Kitagawa M, Ogata T | title = Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence | journal = The Journal of Biological Chemistry | volume = 283 | issue = 9 | pages = 5525–32 | date = February 2008 | pmid = 18162467 | doi = 10.1074/jbc.M703289200 }}
* {{cite journal | vauthors = Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A | title = Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics | journal = Scientific Reports | volume = 3 | pages = 1095 | year = 2013 | pmid = 23393614 | pmc = 3566603 | doi = 10.1038/srep01095 }}
* {{cite journal | vauthors = Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A | title = Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics | journal = Scientific Reports | volume = 3 | pages = 1095 | year = 2013 | pmid = 23393614 | pmc = 3566603 | doi = 10.1038/srep01095 }}

Latest revision as of 18:09, 17 July 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Hes family bHLH transcription factor 3 is a protein that in humans is encoded by the HES3 gene.[1]

References

  1. ↑ "Entrez Gene: Hes family bHLH transcription factor 3".

Further reading

  • Katoh M, Katoh M (August 2004). "Identification and characterization of human HES2, HES3, and HES5 genes in silico". International Journal of Oncology. 25 (2): 529–34. doi:10.3892/ijo.25.2.529. PMID 15254753.
  • Katoh M, Katoh M (August 2007). "Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer". International Journal of Oncology. 31 (2): 461–6. doi:10.3892/ijo.31.2.461. PMID 17611704.
  • Fukami M, Wada Y, Okada M, Kato F, Katsumata N, Baba T, Morohashi K, Laporte J, Kitagawa M, Ogata T (February 2008). "Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence". The Journal of Biological Chemistry. 283 (9): 5525–32. doi:10.1074/jbc.M703289200. PMID 18162467.
  • Park DM, Jung J, Masjkur J, Makrogkikas S, Ebermann D, Saha S, Rogliano R, Paolillo N, Pacioni S, McKay RD, Poser S, Androutsellis-Theotokis A (2013). "Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics". Scientific Reports. 3: 1095. doi:10.1038/srep01095. PMC 3566603. PMID 23393614.
Retrieved from "https://www.wikidoc.org/index.php?title=HES3&oldid=1530898"